• Gamma Biosciences Acquires Stake in Mirus Bio contractpharma
    May 19, 2021
    Gamma Biosciences has agreed to make a controlling investment in Mirus Bio, a developer of biomimetic, cell-adaptive lipid-polymer nanocomplexes (LPNCs) for nucleic acid delivery based in Madison, WI.
PharmaSources Customer Service